Navigation Links
Sanofi Aventis : New Study Results Support the "Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes
Date:9/10/2008

PARIS, September 10 /PRNewswire-FirstCall/ --

- Abstracts 185 and 1112

Sanofi-aventis, a world leader in diabetes care, announced results from two randomized clinical studies presented at the European Association for the Study of Diabetes (EASD) 44th Annual Meeting demonstrating that the "basal plus" insulin strategy with LANTUS(R) (insulin glargine (rDNA origin) injection) once daily (basal insulin) and APIDRA(R) once daily (prandial insulin) (insulin glulisine (rDNA origin) injection) administered at the main meal (defined by the highest postprandial blood glucose level) improve blood glucose levels in patients with type 2 diabetes after basal insulin optimisation.

In the ELEONOR (Optimising basal plus insulin therapy in type 2 diabetes by telecare assistance for self-monitoring of blood glucose) and OPAL (Adding a single dose of insulin glulisine at breakfast or main meal to basal insulin and oral antidiabetic therapy) clinical studies, patients previously treated with LANTUS(R) and oral diabetes medications achieved significantly improved glycaemic control by implementing a "basal plus" regimen - adding one injection of APIDRA(R) at the main meal of the day. In the ELEONOR study, the addition of one APIDRA(R) injection resulted in a further A1C drop of 0.7-0.8%. In the OPAL study, A1C scores improved, significantly dropping 0.4% from baseline to endpoint in both patients that were administered APIDRA(R) at breakfast and patients who were administered APIDRA(R) at main meal.

"With so many people living with diabetes not reaching their A1C goals, we're always looking for new ways to help manage blood glucose levels," said Dr. Del Prato, Professor of Endocrinology and Metabolism and Chief of the Section of Diabetes at the School of Medicine, University of Pisa, Italy. "The results from ELEONOR and OPAL show us that a basal plus strategy is an option for insulin intensification for Type 2 Diabetes insufficiently controlled despite
'/>"/>

SOURCE Sanofi Aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season
2. ThalesNano Inc. and sanofi-aventis R&D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time
3. U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile
4. Sanofi Pasteur Mounts Emergency Response to Yellow Fever Epidemic in Latin America
5. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
6. Sanofi Pasteur and Statens Serum Institut Team Up Against Tuberculosis
7. Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
8. Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur
9. Sanofi Pasteurs Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage
10. Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)
11. Germicidal UVC Lights Improve Clinical Pregnancy Rates for IVF Lab, New Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... SEATTLE , April 1, 2015  Adaptive ... The Lancet Oncology showing ... the company,s next-generation sequencing-based minimal residual disease (MRD) ... clonoSEQ™ MRD test) accurately identifies patients with diffuse ... of relapse after initial treatment, usually several months ...
(Date:4/1/2015)... 01, 2015 Park Systems, ... selected to receive the prestigious “Best Analytic Instrumentation ... NX10 is the premium research-grade True Non-Contact AFM, ... linearity, closed-loop detector noise, and minimized thermal drift. ... n, which allows images with a single click, ...
(Date:4/1/2015)... TORONTO , April 1, 2015 /PRNewswire/ - ... Securities Exchange: PBT.U), is pleased to announce that ... holds 54% equity, has entered into an agreement ... Biohaven,s first clinical trial with their lead compound ... the identification and development of clinical stage neuroscience ...
(Date:4/1/2015)... , April 1, 2015  Among 1,050 U.S. consumers, ... oral cancer (68 percent) and only 36 percent reported ... check-up, according to findings from a survey ... leading innovator and developer of solutions that aid in ... The online survey polled 1,050 U.S. consumers on their ...
Breaking Biology Technology:Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA 2Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA 3Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA 4Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA 5Park Systems Awarded the New Economy Magazine “Best Analytic Instrumentation Company 2014” 2Portage's Biohaven Announces Agreement with inVentiv Health 2Portage's Biohaven Announces Agreement with inVentiv Health 3National Oral Cancer Awareness Survey Reveals Greater Need for Education and Screening Tools for Oral Cancer Among U.S. Adults 2National Oral Cancer Awareness Survey Reveals Greater Need for Education and Screening Tools for Oral Cancer Among U.S. Adults 3National Oral Cancer Awareness Survey Reveals Greater Need for Education and Screening Tools for Oral Cancer Among U.S. Adults 4
... 11, 2012  CBI, a division of Advanstar Communications, is ... Patient Adherence Forum, which is being held April 26 ... PA. At the event, industry experts share their strategies ... collaboration and patient engagement.  Conference highlights ...
... IndustryWeek magazine today named the Life Technologies Corporation ... one of its Top Ten Plants in North America for ... prestigious award.  IndustryWeek noted the plant,s 9% inventory ... 94% error reduction in production documentation process; $4.2 million in ...
... Danish Kroner from the VILLUM FOUNDATION paves the way for ... the world,s leading researcher in the field of quantum physics, ... to find and attract a physicist of international standing the ... grant of 38 million DKK from the VILLUM FOUNDATION. The ...
Cached Biology Technology:Complete Agenda Announced for 11th Annual Patient Adherence Forum 2Life Technologies Plant in Austin, Texas Named One of IndustryWeek's Top Ten Best Plants for 2011 2Life Technologies Plant in Austin, Texas Named One of IndustryWeek's Top Ten Best Plants for 2011 3Life Technologies Plant in Austin, Texas Named One of IndustryWeek's Top Ten Best Plants for 2011 4Niels Bohr Institute gets top researcher from Harvard 2Niels Bohr Institute gets top researcher from Harvard 3
(Date:3/18/2015)... , March 18, 2015 As mobile ... new revolutionary smart wallets and apps continue to be introduced ... entrenched in the mobile payment industry in focus today are:  ... Ltd. (NYSE: BABA ), Apple Inc. (NASDAQ: ... and Facebook Inc. (NASDAQ: FB ) ...
(Date:3/17/2015)... 17, 2015  MecklerMedia Corporation (OTCQX: MECK) announced ... service robots ever held in New ... May 11-13, 2015 at the Javits Convention Center. ... event include: Acorn Product Development; Axis NJ; c-Link ... Robotics; Littler; NewBotic Corporation; Neya Systems LLC; Reliabotics; ...
(Date:3/12/2015)... 12, 2015 The mascots of the Atlantic ... part of Wake Forest Baptist Medical Center. They stopped ... 2015 ACC Men,s Basketball Tournament. Young patients enjoyed bonding ... getting their autographs. Brenner Children,s Hospital is ... the only children,s hospital in northwest North ...
Breaking Biology News(10 mins):Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
... areas with more green space tend to report greater well-being ... green space nearby, according to new research published in ... Science. Examining data from a national longitudinal survey of ... the European Centre for Environment & Human Health at the ...
... are a major cause of disability or premature death in ... already suffered one fragility fracture; they are at twice the ... have not fractured. Nevertheless health care systems around ... leaving them exposed to debilitating and life-threatening secondary fractures. ...
... 2013 Three new studies involving tree nuts (almonds, ... and walnuts) were presented this week at the Experimental ... associated with a better nutrient profile and diet quality; ... and a decrease in several cardiovascular risk factors compared ...
Cached Biology News:Green spaces may boost well-being for city slickers 2New review sets international standards for best practice in fracture liaison services 2New findings on tree nuts and health presented at the Experimental Biology Meeting in Boston, Mass. 2New findings on tree nuts and health presented at the Experimental Biology Meeting in Boston, Mass. 3
MAb to Yersinia pestis F1 Ag. Yersinia pestis F1 Antigen EB Strain...
...
... The Dodeca silver stain kits are ... devices including Bio-Rad Dodeca stainers. This ... quantities of proteins in polyacrylamide gels ... kit includes sensitizer concentrate, silver reagent ...
... thermal cycler holds 96 x 0.2 ml ... heated lid incorporates a thumbwheel to adjust ... vessels for oil-free cycling. Peltier heat pumps ... and ramping rates of up to 1.4 ...
Biology Products: